1,54 €
Deine Einschätzung
China Medical System Holdings Ltd Aktie
Was spricht für und gegen China Medical System Holdings Ltd in den nächsten Jahren?
Pro
Kontra
Rendite von China Medical System Holdings Ltd im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| China Medical System Holdings Ltd | 0,65 % | 9,22 % | 10,00 % | 77,01 % | 10,00 % | 0,00 % | 60,42 % |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | -0,98 % | 4,62 % | 2,00 % | -1,92 % | 4,08 % | -22,73 % | 0,99 % |
| Tianjin Zhon.xin Ph.s Yc1 | 1,40 % | -0,37 % | 4,08 % | 43,70 % | -3,46 % | 176,00 % | 307,59 % |
| Livzon Pharmaceutical Group Inc | 0,63 % | 4,61 % | -7,02 % | 3,25 % | 1,27 % | 3,92 % | 0,63 % |
Kommentare
News
New Rules Says Medicare Advantage Can't Cover These Treatments More Seniors Rely On
Since 2018, Medicare Advantage Plans have had flexibility in what they cover, as the Bipartisan Budget Act of 2018 allowed plans to expand coverage to include Special Supplemental Benefits for the
New Medicare Advantage Rule Forbids Coverage of Procedures Used by Over 4 Million Seniors
Medicare Advantage plans are an alternative to traditional Medicare that can provide coverage for more services. The Bipartisan Budget Act of 2018 allowed Advantage Plans to cover things that were
Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy
BASEL, CH / ACCESS Newswire / November 27, 2025 / Magnolia, a leading global Digital Experience Platform (DXP) provider, is excited to announce that renowned software entrepreneur and



